Cannabis Bioscience International Holdings, Inc. reported earnings results for the third quarter and nine months ended February 29, 2024. For the third quarter, the company reported sales was USD 0.036411 million compared to USD 0.051252 million a year ago. Net loss was USD 0.209192 million compared to USD 0.324655 million a year ago. Basic loss per share from continuing operations was USD 0.00002 compared to USD 0.00004 a year ago.
For the nine months, sales was USD 0.172979 million compared to USD 0.270413 million a year ago. Net loss was USD 0.51541 million compared to USD 0.756574 million a year ago. Basic loss per share from continuing operations was USD 0.00005 compared to USD 0.00009 a year ago.